Aggregated and oligomeric amyloid ␤-protein (A␤) is known to exhibit neurotoxicity. However, the action of A␤ monomers on neurons is not fully understood. We have studied aggregation state-dependent actions of A␤ and found an oligomer-specific effect of A␤ on lipid metabolism in neurons (Michikawa et al., 2001) . Here, we show a novel function of monomeric A␤1-40, which is the major species found in physiological fluid, as a natural antioxidant molecule that prevents neuronal death caused by transition metal-induced oxidative damage. Monomeric A␤1-40, which is demonstrated by SDS-PAGE after treatment with glutaraldehyde, protects neurons cultured in a medium containing 1.5 M Fe(II) without antioxidant molecules. Metal ion chelators such as EDTA, CDTA (trans-1,2-diaminocyclohexane-N,N,NЈ,NЈ-tetraacetic acid), and DTPA (diethylenetriamine-N,N,NЈ,NЉ,NЉ-penta-acetic acid, an iron-binding protein, transferrin, and antioxidant scavengers such as catalase, glutathione, and vitamin E also inhibit neuronal death under the same conditions. Monomeric A␤1-40 inhibits neuronal death caused by Cu(II), Fe(II), and Fe(III) but does not protect neurons against H 2 O 2 -induced damage. Monomeric A␤1-40 inhibits the reduction of Fe(III) induced by vitamin C and the generation of superoxides and prevents lipid peroxidation induced by Fe(II). A␤1-42 remaining as a monomer also exhibits antioxidant and neuroprotective effects. In contrast, oligomeric and aggregated A␤1-40 and A␤1-42 lose their neuroprotective activity. These results indicate that monomeric A␤ protects neurons by quenching metal-inducible oxygen radical generation and thereby inhibiting neurotoxicity. Because aggregated A␤ is known to be an oxygen radical generator, our results provide a novel concept that the aggregation-dependent biological effects of A␤ are dualistic, being either an oxygen radical generator or its inhibitor.
One of the neuropathological hallmarks of Alzheimer's disease (AD) is the formation of extracellular amyloid deposits (Selkoe, 1994) . The major component of the amyloid deposits is the 39 -42 amino acid peptide of the amyloid ␤-protein (A␤) (Glenner and Wong, 1984; Masters et al., 1985) . One of the A␤ species, ending with a C terminus at residue 40 (A␤1-40), is the predominant soluble species in biological fluids (Vigo-Pelfrey et al., 1993; Ida et al., 1996) . The longer form of A␤, ending at residue 42 (A␤1-42), accumulates initially and predominantly in parenchymal plaques (Roher et al., 1993; Iwatsubo et al., 1994) . A␤1-42 is normally produced and secreted by cells in much lower quantities than A␤1-40, which represents ϳ90% of the total secreted A␤. It is believed that aggregated A␤ exerts neurotoxicity and initiates the progressive pathophysiology of AD (Mattson et al., 1993; Pike et al., 1993; Lorenzo and Yankner, 1994; Hartley et al., 1999) . However, the function of monomeric A␤ on neurons is not yet fully understood.
It has been reported that the levels of metals such as zinc, iron, and copper are significantly concentrated in senile plaques (Smith et al., 1997; Lovell et al., 1998b) . These observations followed original reports showing that these metals promote A␤ aggregation (Bush et al., 1994a,b; Huang et al., 1997; Atwood et al., 1998) , which is reversed by treatment with chelators in vitro (Huang et al., 1997) and in vivo (Cherny et al., 2001) . In support of these findings, a recent study has clearly demonstrated that zinc and copper induce non-␤-sheeted A␤ aggregation but inhibit ␤-sheeted aggregation and fibril formation (Yoshiike et al., 2001 ). Other studies have suggested that accumulated metals support the AD pathology as a possible source of reactive oxygen radicals (Smith et al., 1997; Lovell et al., 1998b; Sayre et al., 2000) .
Recent studies showed that the surrounding regions of A␤ deposits in brains of patients with AD and Down's syndrome have no damage (Nunomura et al., 2000 (Nunomura et al., , 2001 and that there is an inverse correlation between A␤ burden and the levels of oxidized nucleic acids in the AD brain (Cuajungco et al., 2000b) . Although aggregated A␤ is reported to generate free radicals (Hensley et al., 1994; Schubert and Chevion, 1995; Kay, 1997; Huang et al., 1999a; Monji et al., 2001b) , these lines of evidence imply a new function of A␤ other than that of a radical generator. A previous report has suggested its antioxidant activity for lipoproteins (Kontush et al., 2001) ; however, no explanation has been provided as to the mechanism behind the disparate results from different laboratories regarding A␤-induced oxidative stress versus others suggesting antioxidant properties.
In light of the above, we have studied the aggregation statedependent actions of A␤ on neurons (Michikawa et al., 2001; Gong et al., 2002) . Here, we show that monomeric A␤1-40 and also A␤1-42 serve as antioxidant molecules protecting neurons from oxygen radicals generated in a metal-dependent manner, providing new insights into the strategy for developing a therapy for patients with AD.
MATERIALS AND METHODS
Reagents and preparation. Synthetic human A␤1-40 was purchased from Peptide Institute Inc. (Osaka, Japan; lot numbers 510116 and 501001) and Bachem (Bubendorf, Switzerland; lot number 0538913). A␤40 -1 (lot number D539530) was purchased from Bachem, and A␤1-42 (lot number 510523), A␤1-16 (lot number 490704), and A␤25-35 (lot number 500701) were purchased from Peptide Institute Inc. A␤1-40, A␤1-42, and A␤25-35 were dissolved in DMSO at 2 mM and then diluted with distilled water to a concentration of 200 M. Although the solution was clear, it is known that an A␤ solution contains short fibrils (Naiki et al., 1998) . To remove short fibrils, A␤ solutions were centrif uged at 100,000 ϫ g for 1 hr at 4°C, using a Beckman Optima TL X table ultracentrif uge and a Beckman TL A-120.2 fixed-angle rotor. A␤1-16 was directly dissolved in water to a concentration of 200 M. Oligomeric A␤1-40 was prepared as described previously (Michikawa et al., 2001) . Transferrin, insulin, progesterone, putrescine, selenite, superoxide dismutase (SOD), catalase, glutathione, vitamin E, and vitamin E acetate were obtained from Sigma (St. L ouis, MO). The B27 supplement and B27 minus antioxidants (B27-AO) were purchased from Invitrogen (Grand Island, N Y). EDTA was purchased from Eastman Kodak Company (Rochester, N Y). trans-1,2-diaminocyclohexane-N,N,NЈ,NЈ-tetra-acetic acid (CDTA), diethylenetriamine-N,N,NЈ,NЉ,NЉ-penta-acetic acid (DTPA), iron sulfate heptahydrate, iron nitrate nonahydrate, and copper sulfate pentahydrate were obtained from Wako Pure Chemical Industries, L td. (Osaka, Japan). Monoclonal antibody, namely, anti-4-hydroxy-2-nonenal (4-HN E) antibody, which recognizes oxidized 4-HN E, was purchased from NOF Corporation (Tokyo, Japan).
Cell culture. All experiments were performed in compliance with existing laws and the institutional guidelines. C erebral cortical neuronal cultures were prepared from Sprague Dawley rats at embryonic day 17 as described previously (Michikawa and Yanagisawa, 1998) . The dissociated single cells were suspended in a feeding medium and plated onto poly-D-lysine-coated 12-well plates at a cell density of 5 ϫ 10 Ϫ5 . The feeding medium consisted of DM EM / F12 containing 0.1% bovine albumin fraction V solution (Invitrogen) and N2 (Bottenstein and Sato, 1979) , B27, or B27-AO supplements.
Quantification of neuron survival. For assessment of cell viability of cultured neurons, phase-contrast photomicrographs were taken before treatment and at various time points after treatment. The number of viable neurons on each micrograph was determined in premarked microscope fields (10ϫ objective). Viable neurons were identified on the basis of morphological criteria. Neurons with intact neurites with uniform diameter and soma with a smooth round appearance were considered viable, whereas neurons with fragmented neurites and shrunken cell bodies were considered nonviable. In a pilot study, cell viability was confirmed by testing cell membrane permeability using propidium iodide (PI) or by staining with a viable cell-specific marker, calcein AM, as described previously (Michikawa and Yanagisawa, 1998) . Neurons were stained with Hoechst 33342 (bis-benzamide; 2.5 g /ml), to visualize their nuclear morphology. Most neurons died during culturing in DM EM / F12 medium supplemented with B27-AO (B27-AO medium) or DM EM / F12 medium supplemented with N2 and FeSO 4 , CuSO 4 , or Fe(NO 3 ) 3 . For each determination of cell viability, 1000 -1400 cells were counted.
T hioflavin-T binding assay for ag gregated A␤. Determination of the aggregated state of A␤ in solution was performed on the basis of a previously established method (LeVine, 1995; LeVine, 1999) . The conditioned media, in which the cultures were incubated with A␤, were collected. Each well contained 50 l of each medium in 1 ml per well of 5 M thioflavin-T in 50 mM glycin-NaOH, pH 8.5. Steady-state fluorescence intensities for each sample were determined in 48-well plates with a multiplate reader (Fluoroskan Ascent, Labsystems Inc., Franklin, M A) (excitation 446 nm, emission 490 nm). The culture media to which A␤ was not added were used as the background.
Cross-link ing of A␤ with glutaraldehyde. SDS-PAGE of cross-linked fA␤1-40 and iA␤1-40 was performed as described previously (Levine, 1995) . Briefly, 8 g of each peptide in a stock solution (200 M) was diluted to 35 l with H 2 O. One-tenth volume of glutaraldehyde (3.5 l of 0.625% diluted from a 25% stock solution) was added to each solution followed by the addition of an excess amount of NaBH 4 (10 l of 0.175 M, 6.6 mg /ml, in 0.1 M NaOH). After 10 min of incubation, 15 l of the SDS-PAGE sample buffer containing 100 mM dithiothreitol and 20% sucrose was added. Boiling of the amyloid peptides in the sample buffer was avoided, because SDS-resistant multimeric complexes are formed from non-cross-linked peptides during heating in SDS (LeVine, 1995).
Then, 20 l of the mixture was subjected to SDS-PAGE using a 4 -20% gradient gel as described previously (Michikawa et al., 2001) . The gel was then visualized by silver staining. To compare the aggregation status of A␤1-40 and A␤1-42 in 8 mM sodium phosphate, pH 7.4, or DM EM / F12 medium, freshly dissolved A␤1-40 and A␤1-42 were incubated at 20 M for 3 hr at 37°C in each solution. The protein concentration of each solution of A␤1-40 and A␤1-42 was determined, 2.8 g of each peptide was subjected to cross-linking, and the peptides were subjected to electrophoresis and silver staining.
Iron reduction assays. Assays were performed according to a previously reported method (Huang, 1999a) . A␤1-40 (10 M), A␤1-42 (10 M), DTPA (10 and 300 M) or Fe(III) (25 M), and 3-(2-pyridyl)-5,6-bis(4-sulfo-phenyl)-1,2,4-triazine (PDT) (250 M) were added to 1 ml of 8 mM sodium phosphate, pH 7.4, and rotated at 25°C for 6 hr. Vitamin C (10 M) was then added, and the mixture was f urther incubated at 37°C for 14 hr. A solution containing Fe(III) and A␤1-40 at the same concentrations in the absence of the indicator PDT was used to determine the background levels of this assay system. The absorbance at 562 nm indicates the amount of reduced iron ion, Fe(II).
Measurement of superoxide levels. The levels of intracellular superoxide anion radicals were measured using hydroethidium (H E), which is oxidized to a fluorescent ethidium cation by superoxides, using methods similar to those described previously (Bindokas et al., 1996) . In brief, cells were incubated for 30 min in the presence of 5 M H E (Molecular Probes, Eugene, OR) at 37°C in 5% CO 2 atmosphere, and confocal images of cell-associated H E fluorescence were acquired (excitation ϭ 488 nm and emission Ͼ560 nm).
Western blot anal ysis for determination of lipid peroxidation. C erebral cortices of Sprague Dawley rats at embryonic day 17 were isolated and minced with a cutter and incubated in PBS in the presence of 3 or 5 M Fe(II) with or without fA␤1-40 at 10 M for 4 hr at 37°C. The fragments were then homogenized in RI PA buffer (150 mM NaC l, 10 mM Tris-HC l, pH 7.5, 1% Nonidet P-40, 0.1% SDS, and 0.25% sodium deoxycholate) and centrif uged at 10,000 ϫ g for 10 min at 4°C, and the supernatants were recovered. Protein concentrations of the supernatants were determined by the BCA method (Pierce, Rockford, IL). Western blot analysis was performed according to the methods described previously (Michikawa et al., 2001) . In brief, 24 g of each protein was separated by 4 -20% gradient SDS-PAGE and electrotransferred onto nitrocellulose membranes. The membranes were incubated with monoclonal primary antibody, anti-4-HN E antibody, at 2 g /ml overnight at 4°C. The membranes were then washed in PBS containing 0.05% T ween 20 (PBS-T) three times, followed by incubation with HRP-conjugated goat antimouse IgG (1:5000 dilution) for 1 hr at room temperature. The membranes were washed four times in PBS-T and visualized with an ECL kit (Amersham Pharmacia Biotech, Buckinghamshire, UK).
RESULTS

Freshly dissolved A␤1-40 protects neurons against death induced by antioxidant-depleted medium
We studied the effect of A␤1-40 on neuronal viability. The medium used was DMEM nutrient mixture (DMEM/F12, 50:50) containing B27-AO. When neurons were incubated in the B27-AO medium, cultured neurons appeared healthy 40 hr after plating; however, neuronal death was induced 48 hr after plating, and most of the cells were dead 64 hr after plating (Fig. 1a-c) . In contrast, neuronal death was inhibited in the presence of freshly dissolved A␤1-40 (fA␤1-40) at a concentration of 5 M 64 hr after plating (Fig. 1d) . Addition of DMSO at a final concentration of 1% DMSO to the B27-AO medium did not prevent or accelerate neuronal death (Fig. 1e) . Figure 1e shows the timedependent curves of neuronal viability of the cultures treated with fA␤1-40 at various concentrations. The neuronal death induced by incubation in the B27-AO medium was inhibited by fA␤1-40 in a dose-dependent manner. Neuronal viability was maintained at the initial levels when the cultures were treated with fA␤1-40 at concentrations of 10 and 20 M until 4 d after the commencement of the treatment (Fig. 1e) . The neurons at each time point were stained with Hoechst 33342 and PI. The viable neurons at culture day 2 had larger swollen cell bodies (Fig. 1b) , and the nuclei of dead neurons were shrunken as demonstrated by Hoechst 22336 and PI staining (Figs. 1f,h ). The effect of freshly prepared A␤1-42 on neuronal viability was also examined. fA␤1-42 could not inhibit neurotoxicity but rather promoted neuronal death (Fig. 1e ).
Monomeric A␤1-40, but not oligomeric A␤1-40, has an ability to protect neurons in the B27-AO medium
We examined the effect of incubated A␤1-40 (iA␤1-40), which was filtered and the protein concentration of which was determined before addition, on neuronal viability cultured in the B27-AO medium. As shown in Figure 2a , neuronal death occurred 72 hr after the commencement of the treatment, which was completely inhibited by fA␤1-40, but not by iA␤1-40, at a concentration of 5 M. Results of the quantitative analysis of neuronal viability within 72 hr of incubation are shown in Figure 1b , showing that fA␤1-40 at concentrations of 5 and 10 M completely inhibited neuronal death, whereas iA␤1-40 inhibited neuronal death at 10 M but not at 5 M. To determine the oligomeric state of A␤, the reaction of the conditioned medium of each culture with thioflavin-T was determined. As shown in Figure 2c , the value of the conditioned medium of the cultures treated with iA␤1-40 was significantly higher than that treated with fA␤1-40, indicating that iA␤1-40 contains highly oligomerized A␤. To determine more directly that the amount of monomeric A␤ was decreased and that of oligomeric A␤ was increased, a crosslinking study of each A␤ sample was performed. As shown in Figure 2d , fA␤1-40 contains mostly monomers, whereas iA␤1-40 contains many oligomers, including dimers, trimers, and tetramers, in addition to decreased levels of monomers. These results indicate that A␤ monomers have a neuroprotective activity and that the lack of neuroprotective activity of iA␤1-40 at 5 M is not caused by its toxic effect on neurons but rather by the low levels of monomers.
Metal-binding protein and metal chelators inhibit neuronal death in the B27-AO medium
Because neurotoxicity was induced in the media deficient of antioxidant reagents, it is reasonable to assume that the A␤-mediated neuronal protection may possibly be explained by an antioxidant action of A␤. Antioxidant actions include a direct antioxidant effect, and the indirect actions of fA␤1-40 include quenching of metal ions to inhibit secondary generation of free radicals. Thus, we examined the effect of molecules that have antioxidant activities. As shown in Figure 3a , catalase, glutathione, vitamin E acetate, and vitamin E inhibited neuronal death at culture day 2. Catalase and vitamin E acetate and vitamin E partially and completely inhibited cell death at culture day 4, respectively; however, SOD did not show any neuroprotective activity. Because we have observed that the N2 supplements (Bottenstein and Sato, 1979) inhibited neuronal death induced by incubation in the B27-AO medium, we examined the inhibitory effect of each component of N2 supplements. Figure 3b shows that among the components examined, only transferrin successfully inhibited neuronal death. Because transferrin is known to bind iron, inhibiting cell death by quenching the iron-dependent generation of reactive oxygen radicals (Halliwell and Gutteridge, 1989) , it is reasonable to postulate that iron in DMEM/F12 plays a critical role in neuronal death in the B27-AO medium. Thus, we next examined the effect of various iron chelators on neuronal death under these conditions. EDTA (400 M), CDTA (40 M), and DTPA (8 M) protected neurons against toxicity induced in the B27-AO medium at culture day 4 (Table 1 ). 
Monomeric A␤1-40 protects neurons against iron-and copper-mediated neuronal toxicity
Because the culture medium, DMEM/F12 supplemented with B27-AO, contains 1.5 M Fe (II), 124 nM Fe(III), and 5.2 nM Cu(II), our findings that neuronal death induced in the B27-AO medium is prevented by antioxidant scavengers, metal chelators, and transferrin indicate that neurotoxicity is induced by oxygen radicals generated in an Fe(II)-mediated manner. Thus, we next determined whether transition metal ions, such as iron and copper ions, and H 2 O 2 exhibit neurotoxicity on cultured neurons, and whether fA␤1-40 has the ability to prevent this toxicity. Twentyfour hours after plating, neuronal cultures were treated with 1.5 M CuSO 4 , 3.0 M FeSO 4 , 25 M Fe(NO 3 ) 3 , and 30 M H 2 O 2 in the presence or absence of 5 M fA␤1-40 in the N2 medium. After 24 hr incubation, photographs were taken, and the neuronal viability was determined. As shown in Figure 4 , Cu(II), Fe(II), Fe(III), and H 2 O 2 caused cell death (a, c, e, and g, respectively) . fA␤1-40 at a concentration of 5 M inhibited cell death caused by these metals (Fig. 4b,d ,f ) but did not inhibit cell death caused by H 2 O 2 (Fig. 4h) , indicating that protection of neurons by fA␤1-40
is not caused by a direct antioxidant activity but by an indirect one via interaction with metal ions. The quantitative analysis of these experiments is shown in Figure 4i . We performed additional experiments to determine the effect of transferrin on neuronal toxicity induced by these metals. We found that 3.8 M transferrin inhibited 3.0 M Fe(II)-and 25 M Fe(III)-mediated neurotoxicity, but even 13 M transferrin did not inhibit 1.5 M Cu(II)-mediated neurotoxicity (data not shown), supporting the idea that Fe(II) but not Cu(II) is responsible for the generation of oxygen radicals and induces toxicity. This is supported by the fact that the B27-AO medium contains 1.5 M Fe(II), which is sufficiently high to induce cell toxicity, whereas it contains much lower concentrations of Cu(II) and Fe(III). Transferrin and antioxidant scavengers inhibit neuronal death that occurred in the B27-AO medium. a, SOD (1500 U/ml), catalase (21,600 U/ml), glutathione (450 g/ml), vitamin E acetate (1 g/ml), or vitamin E (1 g/ml) was added to neuronal cultures maintained in the B27-AO medium 4 hr after plating. b, N2 supplements or each component of N2 supplements, transferrin (100 g/ml), insulin (5 g/ml), progesterone (0.0063 g/ml), putrescine (16.11 g/ml), and selenite (0.0052 g/ml) was added to neuronal cultures maintained in the B27-AO medium 4 hr after plating. Neuronal viability was determined as described in Materials and Methods at culture days 1, 2, and 4 ( a) or 1, 2, and 7 (b). Primary cortical neurons were cultured in the B27-AO medium. Four hours after plating, the cultures were incubated with metal chelators. Cell viability was determined 48 h after the start of treatment. The data represent means Ϯ SE. n ϭ 6 each. Three independent experiments showed similar results.
Monomeric A␤1-40 inhibits vitamin C-mediated reduction of Fe(III)
Because reduced metal ions are known to generate oxygen radicals that initiate subsequent reactions of radical productions (Halliwell and Gutteridge, 1984), we determined whether fA␤1-40 has any effect on Fe(III) reduction. To examine the inhibitory effect of fA␤1-40 on Fe(III) reduction, a vitamin C-mediated metal reduction system was used. As shown in Figure 5a , fA␤1-40 inhibited Fe(III) reduction mediated by vitamin C. In addition to fA␤1-40, fA␤1-42, A␤1-16, A␤25-35, and a metal ion chelator, DTPA, also inhibited Fe(III) reduction. Because the action of A␤ is known to depend on the state of aggregation of the peptides, we next determined the aggregation states of A␤ used in this study by cross-linking of peptides with glutaraldehyde and subsequent silver staining. As shown in Figure 5b , most of both A␤1-40 and A␤1-42 incubated in 8 mM sodium phosphate buffer and A␤1-40 incubated in DMEM/F12 for 3 hr were found to be monomers, whereas fA␤1-42 incubated in DMEM/F12 for 3 hr was found to form aggregation (Fig. 5b, ‫,) ء‬ and the amount of monomeric A␤1-42 was significantly decreased (Fig. 5b) .
Generation of superoxides in the B27-AO medium and Fe(II)-induced lipid peroxidation are inhibited by monomeric A␤1-40
Using HE dye, we examined whether the generation of oxygen radicals is enhanced in the B27-AO medium and whether this enhancement is inhibited by fA␤1-40. As shown in Figure 6a , strong signals of oxidized ethidium dye were observed in some viable neurons with swollen cell bodies (Fig. 6a, arrows) and dead neurons with shrunken cell bodies (Fig. 6c) , whereas the signals with ethidium dye in the cultures treated with fA␤1-40 (5 M) were not detected (Fig. 6b) . We then examined the effect of fA␤1-40 on Fe(II)-induced lipid peroxidation in rat brain cortices by investigating the production of 4-HNE-modified proteins, a product of lipid peroxidation in rat brains, using a monoclonal antibody against 4-HNE-modified proteins. As shown in Figure   Figure 4 . f A␤1-40 inhibits neuronal death induced by transition-metal ions. Neurons were cultured in N2 medium for 24 hr, followed by treatment with 1. (Table 2 ). In the case of A␤1-42, the thioflavin-T value of the culture medium at the end of treatment significantly increased compared with that of the culture medium treated with A␤1-40, A␤1-16, or A␤25-35, indicating that A␤1-42 becomes highly aggregated in a culture medium. However, because A␤1-40, when it remains as a monomer, has an antioxidant effect in the in vitro assay system (Fig. 5a) , we next performed an experiment to determine whether monomeric A␤1-42 at a concentration of 5 M has a neuroprotective effect on neurons. Because Congo red is known to inhibit oligomerization of A␤ by stabilizing A␤ monomer (Podlisny et al., 1995 (Podlisny et al., , 1998 , we used Congo red to maintain A␤1-42 as a monomer. As shown in Table 2 , concurrent treatment of 100 M Congo red with 5 M A␤1-42 inhibited neuronal death, whereas treatment with 100 M Congo red alone did not. The thioflavin-T value of these conditioned media was not determined, because Congo red affects the thioflavin-T assay system. These data indicate that monomeric A␤, regardless of its species, A␤1-40 or A␤1-42, rescues neurons.
Effect of tachykinin neuropeptides on monomeric A␤1-40-mediated neuroprotection
Because a previous study has demonstrated the neurotrophic effects of A␤1-40, which can be reversed by tachykinin neuropeptides (Yankner et al., 1990) , we further examined whether the neuroprotective effect of monomeric A␤1-40 is inhibited by tachykinin neuropeptides. In our culture system, takykinine neuropeptides such as substance P, physalaemin, eledoisin, neurokinin A, and neurokinin B at 1, 2, 5, 10, and 20 M did not inhibit neuronal death. Moreover, substance P and physalaemin did not inhibit the neuroprotective effect of A␤1-40 (Table 3) . These results indicate that the mechanism underlying the neurotrophic effects of A␤1-40 is different from that underlying the antioxidant functions of monomeric A␤.
DISCUSSION
In this study, we demonstrated a novel function of monomeric A␤1-40 as an antioxidant molecule on cultured neurons. Monomeric A␤1-40 exhibits a neuroprotective effect on neurons by quenching transition metal-mediated oxygen radical generation; however, oligomeric A␤1-40 loses its neuroprotective activity. Monomeric A␤1-42 also exhibits a neuroprotective effect; however, when monomeric A␤1-42 is incubated in the culture medium, it rapidly aggregates and exhibits neurotoxicity, whereas monomeric A␤1-40 remains as a monomer under the same conditions and protects neurons. These findings indicate a novel concept that the biological action of A␤ is dualistic. A␤, as a monomer, functions as an antioxidant molecule, preventing the generation of oxygen radicals, whereas oligomerized or aggregated A␤ not only loses its antioxidant activity but also contributes to the generation of oxygen radicals (Kay, 1997; Monji et al., 2001a,b) , disrupts lipid homeostasis (Michikawa et al., 2001; Gong et al., 2002) , and eventually exhibits neurotoxicity (Mattson et al., 1993; Pike et al., 1993; Lorenzo and Yankner, 1994) . Neuronal death induced in the B27-AO medium is inhibited by the addition of radical scavengers, indicating that neuronal toxicity is caused by oxygen radicals. The B27-AO medium contains 1.5 M Fe(II), 124 nM Fe(III), and 5.2 nM Cu(II), and redox-active transition metals such as iron and copper are known to stimulate oxygen radical chain reactions (Halliwell and Gutteridge, 1984) . Because 1.5 M or higher concentrations of Fe(II) and Cu(II) induce neuronal death in culture [our unpublished data and previous reports (White et al., 1999; Wang and Cynader, 2001) ], Fe(II) is most likely responsible for inducing neurotoxicity by generating oxygen radicals in the B27-AO medium. Furthermore, Figure 6 . fA␤1-40 inhibits the generation of superoxide and lipid peroxidation. Neurons were treated with (a, c) or without (b, d) 5 M fA␤1-40 4 hr after plating and were cultured for 48 hr in the B27-AO medium. The cultures were then incubated with 5 M HE fluorescence (a, b) for 30 min, and transmissive light micrographs of these cultures were taken. Note that the increased signal of superoxides was observed in swollen neurons (arrows) as well as in shrunken neurons in cultures without fA␤ ( a). e, The effect of A␤ on the production of lipid peroxidation in rat cerebral cortices in the presence of Fe(II). Cerebral cortices were isolated, minced with a cutter, and incubated in PBS in the presence of 3 and 5 M Fe(II) with or without fA␤1-40 at 10 M for 4 hr at 37°C. The fragments were then homogenized in RIPA buffer and centrifuged at 10,000 ϫ g for 10 min at 4°C. The supernatant of the homogenate was subjected to Western blot analysis using anti-4-HNE antibody as the primary antibody.
the facts that transferrin successively protects neurons in the B27-AO medium (Fig. 3b ) and inhibits Fe(II)-mediated neuronal death in N2 medium, whereas it does not prevent Cu(II)-induced neuronal death (data not shown), strongly support this notion. Thus, it is possible that fA␤1-40 protects neurons from oxygen radicals generated in an Fe(II)-mediated manner.
Antioxidant actions include a direct antioxidant action such as that of scavengers and indirect actions including the quenching metal ions to inhibit secondary generation of free radicals. The neuroprotective activity of monomeric A␤1-40 includes an inhibitory effect on the generation of superoxides in cultured neurons and lipid peroxidation in brains (Fig. 6) . Furthermore, the direct inhibitory effects of monomeric A␤1-40 on metal reduction induced by vitamin C are also demonstrated (Fig. 5) . These findings, together with the result showing that monomeric A␤1-40 does not serve as a radical scavenger (Fig. 4) , indicate that the neuroprotective activity of A␤1-40 is not caused by a direct antioxidant effect but rather by an indirect effect of this peptide, probably the sequestration of metal ions leading to the quenching of the secondary generation of oxygen radicals as other metal-binding proteins do (Halliwell and Gutteridge, 1989) .
Free-radical involvement in AD pathogenesis is a well established hypothesis (Lovell et al., 1998a; Markesbery and Lovell, 1998) . A␤ is widely believed to serve as a neurotoxic molecule by producing oxygen radicals leading to cell dysfunction and death (Behl et al., 1994; Hensley et al., 1994) . The oxygen radicals generated by the interaction of A␤ with redox-active metal ions are suggested to be the possible source of A␤ neurotoxicity, which is suppressed by the redox-inactive form of zinc or metal ion chelators (Huang et al., 1999a,b; Cuajungco et al., 2000a) . These lines of evidence seem to contradict our present results that monomeric A␤1-40 is a potent antioxidant molecule. This discrepancy can be explained by the notion that the action of A␤ is aggregation state-dependent. We show that monomeric A␤1-40 protects neurons from metal-induced neurotoxicity, whereas iA␤1-40 contains fewer A␤ monomers but more oligomers (Fig.  2d) , which could be the reason for the loss of its neuroprotective ability. This is also the case for A␤1-42, because we have found that A␤1-42, remaining as a monomer in PB, inhibits the reduction of Fe(III) caused by vitamin C as does A␤1-40 (Fig. 5a ), indicating that monomeric A␤1-42 also functions as an antioxidant molecule. In addition, the finding that A␤1-42, when it is maintained as a monomer by coincubation with Congo red in DMEM/F12 medium, exhibits neuroprotective activity (Table 2) strongly supports this notion. However, when fA␤1-42 is incubated in DMEM/F12 medium that contains salt, it aggregates rapidly (Fig. 5b, Table 2 ) and exhibits neurotoxicity (Fig. 1e , Table 2 ), whereas fA␤1-40 remaining as a monomer under the same conditions protects neurons (Figs. 1e, 5b) . Thus, under physiological conditions, A␤1-42, a highly amyloidogenic peptide, rapidly aggregates, loses its neuroprotective activity, generates free radicals, and subsequently exhibits neurotoxicity (Pike et al., 1993; Lorenzo and Yankner, 1994; Roher et al., 1996; Kay, 1997; Huang et al., 1999b; Cuajungco et al., 2000b; Monji et al., 2001a,b) . These lines of evidence suggest that it may not the differences in A␤ species, A␤1-40 or A␤1-42, but those in the state of aggregation, monomers, or other states of aggregation such as oligomers or fibrils, that determine whether the action of A␤ is either neuroprotective or neurotoxic.
Another possible explanation for the discrepancy between the effect of A␤1-40 and that of A␤1-42 on neuronal survival may be that at low iron/A␤ binding ratios, iron is captured by A␤ and sequestered from inducing oxygen radical generation, but at higher iron/A␤ ratios, the interaction of A␤ and iron promotes oxygen radical generation (Huang et al., 1999a) . Because A␤1-42 is suggested to bind iron with greater affinity than A␤1-40 (Atwood et al., 2000) , it may be possible to postulate that A␤1-42 may acquire gain of adverse action at lower concentrations than A␤1-40.
One may say that because a previous study has demonstrated that aggregated A␤ does not lose the stoichiometry of copper binding (Atwood et al., 2000) , an increased amount of oligomer- ized A␤ may undergo oxidization, reduce metal ions, and serve as an oxygen radical generator (Huang et al., 1999a) , leading to neuronal death. Actually, at present we have no evidence indicating that oligomeric A␤ has lesser binding affinity to iron than monomeric A␤. This may be the case for A␤1-42, because A␤1-42 that rapidly aggregates in the culture medium not only loses its neuroprotective activity but also exhibits neurotoxicity (Fig. 1e) ; however, this may not be the case for A␤1-40. Our findings that 5 M iA␤1-40 loses its neuroprotective effect on neurons, whereas 10 M iA␤1-40 protects neurons (Fig. 2b) , do not favor the idea that the loss of neuroprotective function is caused by oxidized oligomeric A␤ but favor the notion that monomeric but not oligomeric A␤1-40 can serve as an antioxidant molecule.
The last question to be addressed is that the neuroprotective effects of monomeric A␤1-40 shown in our present study are the same as the previously reported neurotrophic effects of A␤1-40, which can be reversed by tachykinin neuropeptides (Yankner et al., 1990) . However, monomeric A␤1-40 has a neuroprotective effect even on mature neurons at high concentrations, whereas takykinin neuropeptides including substance P and physalaemin at 10 and 20 M did not inhibit neuronal death in our culture system. Moreover, substance P and physalaemin did not reverse the neuroprotective effect of A␤1-40 (Table 3 ), indicating that the mechanism underlying the neurotrophic effects of A␤1-40 is different from that underlying the antioxidant functions of monomeric A␤.
The notion that monomeric A␤1-40 functions as an antioxidant is supported by previous studies showing that the surrounding regions of A␤ deposits in the brains of patients with AD and Down's syndrome have no damage (Nunomura et al., 2000 (Nunomura et al., , 2001 and that the inverse correlation is found between A␤ burden and levels of oxidized nucleic acids in AD brain (Cuajungco et al., 2000b) . Interestingly, a recent report suggests that brain oxidative damage occurs before A␤ accumulation in the brains of a model mouse of AD amyloidosis (Pratico et al., 2001) . Previous reports have shown that A␤1-42 accumulates with aging, whereas A␤1-40 does not but accumulates in AD brains (Funato et al., 1998) , and that oxidative stress promotes amyloidogenesis (Misonou et al., 2000) . These lines of evidence may allow us to assume that oxygen radicals generated in an age-dependent manner enhance generation of A␤, which may protect neurons from oxygen radical toxicity generated by metal-dependent chain reactions. However, with the increasing amount of A␤ serving as an antioxidant, A␤ aggregates with longer incubation periods in extracellular local fluid and, in turn, exhibits neurotoxicity.
On the basis of our findings, we envisage that A␤ may serve dual actions both by being involved in mechanisms attempting to quench oxidative stress and neurotoxicity probably by sequestrating metal ions when A␤ is in a monomeric state and by exhibiting neurotoxicity when A␤ is highly oligomerized and aggregated by generating oxygen radicals in a metal-mediated manner. Hence, although the toxic actions of A␤ have been exaggerated to date, our observations may provide a new insight into the strategies for development of AD therapy that not only reduction of the amount of A␤ but also inhibition of A␤ aggregation could be the pivotal target for AD therapy.
